Sex is not an independent risk factor for survival in differentiated thyroid cancer

Laryngoscope

Volumn 123, Issue 11, 2013, Pages 2913-2919

  Oyer, Sam L ^a   Smith, Valerie A ^a   Lentsch, Eric J ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

and End Results database; Differentiated thyroid cancer; Epidemiology; sex; Surveillance; survival

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; DIFFERENTIATED THYROID CANCER; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLICULAR THYROID CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENTIATION; THYROID CARCINOMA; TUMOR VOLUME;

AND END RESULTS DATABASE; DIFFERENTIATED THYROID CANCER; EPIDEMIOLOGY; SEX; SURVEILLANCE; SURVIVAL;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 84886951713     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24018     Document Type: Article

References (27)

1. Gilliland FD, Hunt WC, Morris DM, Key CR,. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973-91. Cancer 1997; 79: 564-573.
2. Shaha A,. Treatment of thyroid cancer based on risk groups. J Surg Oncol 2006; 94: 683-691.
3. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
4. Siironen P, Louhimo J, Nordling S, et al. Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumor Biol 2005; 26: 57-64.
5. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY,. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging. Ann Surg Onc 2006; 14: 730-738.
6. Ito Y, Miyauchi A, Jikuzono T, et al. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World J Surg 2007; 31: 838-848.
7. Chow SM, Law SC, Au SK, et al. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute. Head Neck 2002; 24: 670-677.
8. Rago T, Fiore E, Scutari M, et al. Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol 2010; 162: 763-770.
9. Witt R, McNamara AM,. Prognostic factors in mortality and morbidity in patients with differentiated thyroid cancer. Ear Nose Throat J 2002; 81: 856-863.
10. Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PBD,. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997; 82: 3553-3562.
11. Ito Y, Miyauchi A,. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J 2009; 56: 177-192.
12. Passler C, Scheuba C, Prager G, et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 2004; 11: 131-139.
13. Lo CY, Chan WF, Lam KY, Wan KY,. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 2005; 242: 708-715.
14. SEER Brochure. National Cancer Institute. NIH Publication No. 12-4772. March 2012. Available at: http:www//seer.cancer.gov/about/factsheets/SEER- brochure.pdf. Accessed August 15, 2012.
15. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY,. Staging systems for papillary thyroid carcinoma: A review and comparison. Ann Surg 2007; 246: 114-121.
16. Cady B, Sedgwick CE, Meissner WA, Bookwalter JR, Romagosa V, Werber J,. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976; 184: 541-553.
17. 131I therapy. Ann Surg Oncol 1998; 5: 329-337.
18. Scuito R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL,. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol 2009; 20: 1728-1735.
19. Lin JD, Hsieh SH, Chang HY, Huang CC, Chao TC,. Outcome after treatment for papillary thyroid cancer. Head Neck 2001; 23: 140-146.
20. Kurozumi K, Makao K, Nishida T, Makahara M, Ogino N, Tsujimoto M,. Significance of biologic aggressiveness and proliferating activity in papillary thyroid carcinoma. World J Surg 1998; 22: 1237-1242.
21. Papageorgiou MS, Liratzopoulos N, Karanikas M, Efremidou EI, Minopoulos G, Manolas KJ,. Epidemiology and survival of patients with well-differentiated thyroid cancer subjected to total thyroidectomy in Thrace area, Northern Greece: a 20-year experience. Minerva Chir 2010; 62: 137-143.
22. Kjellman P, Zedenius J, Lundell G, et al. Predictors of outcome in patients with papillary thyroid carcinoma. Eur J Surg Oncol 2006; 32: 345-352.
23. Lin JD, Chao TC, Weng HF, Ho YS,. Prognostic variables on papillary thyroid carcinomas with local invasion. Endocr J 1999; 46: 91-98.
24. Machens A, Hauptmann S, Dralle H,. Disparities between male and female patient with thyroid cancers: sex difference or gender divide? Clin Endocrinol 2006; 65: 500-505.
25. Rajoria S, Suriano R, George AL, et al. Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomed Pharmacother 2012; 66: 151-158.
26. Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L,. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study Cohort. Cancer Epidemiol Biomarkers Prev 2011; 20: 1751-1759.
27. Tseng WH, Martinez SR,. Tumor location predicts survival in cutaneous head and neck melanoma. J Surg Res 2011; 167: 192-198.